Skip to main content

Change location

You are currently on the USA (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
  • Product Security
  • Sign up
    • USA (English)
  • We are Bracco Diagnostics
    We are Bracco

    Welcome to a World of contrasts

    • Bracco at a glance
    • Past, present, future
    • Our Foundation
    • Our business
  • Our portfolio

    To order products go to myorders.bracco.com

    • X-ray & CT
      • Products

        • ISOVUE and Imaging Bulk Package
        • GASTROGRAFIN
        • READI-CAT 2 SMOOTHIE
        • READI-CAT 2
        • TAGITOL V
      • Fluoroscopy

        • VARIBAR
        • CYSTOGRAFIN
        • CYSTOGRAFIN-DILUTE
        • E-Z-DISK
        • E-Z-GAS II
        • E-Z-HD
        • E-Z-PAQUE
        • ENTERO VU
        • GASTROGRAFIN
        • Liquid E-Z-PAQUE
      • Myelography

        • ISOVUE-M 200/300
      • Medical devices

        • Empower CTA+
        • NEXO
        • PROTOCO2L TOUCH
    • MRI
      • Contrast agents

        • VUEWAY
        • MultiHance
        • ProHance
      • Medical Devices

        • Max 3
        • EmpowerMR
      • AI

        • AiMIFY
      • Other

        • CitraClear™
    • Ultrasound
      • Contrast agents

        • LUMASON
    • Nuclear medicine
      • Products

        • CardioGen-82
        • HeartSee
        • Kinevac
        • Choletec
    • Cardiology
      • Contrast agents

        • CardioGen-82
        • Lumason
        • ISOVUE
        • ACIST CVi
        • Heartsee
    • Digital solutions
    • Reimbursement
    • Oncology
  • Bracco innovation—the driving force behind everything we do, building upon our unique culture of research and discovery.
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage
  • Knowledge header
    Knowledge

    Current activities and future opportunities

    • Educational programs
    • Partnerships and sponsorships
    • Events
  • bracco sustainability report
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
Page
Bracco Diagnostics Inc.’s Coordinated Vulnerability Disclosure Program The Coordinated Vulnerability Disclosure Program applies to all commercially available Bracco Diagnostics Inc. software-enabled products. This program is designed as a resource for security researchers to report security vulnerabilities to Bracco Diagnostics Inc.
No image available
Page
Events Learning is an infinite game. That's why we support the most prestigious annual medical conferences – where knowledge is shared for the benefit of all.
A healthcare event.
Article
Bracco’s HeartSee: New Features for CAD Diagnosis and Ease of Use Bracco Diagnostics Inc. announced today significant upgrades to its innovative HeartSeeTM software, a leading diagnostic tool used in myocardial blood flow (MBF) quantification with cardiac positron emission tomography (PET) imaging.
Bracco and HeartSee logo
Page
The Bracco Foundation: A culture based on values The origins of the Bracco Foundation lie in the heritage of values passed down for nearly a century from the Bracco family and the Bracco Group, fostering a sense of Corporate Social Responsibility. The Foundation aims to create and spread expressions of culture, art, and science as means for improving our quality of life. It pays specific attention to women and younger generations, encouraging social cohesion.
Bracco Foundation
Article
New Nationwide Real-World Data Validates the Safety of LUMASON® UEA in Contemporary Echocardiographic Practice Bracco Diagnostics Inc. announced today that the results of a nationwide real-world study, published by Dr. Strom et al. in the Journal of the American Heart Association on 14 May 2025, provide valuable information on safety outcomes of cardiac ultrasound procedures in contemporary practice in the United States.
Logo Bracco
Article
Bracco Imaging earns its first EcoVadis Platinum Medal: in Global Top 1%
No image available
Article
RSNA 2025 - Cloned
No image available

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182